|
Lawmakers, Generic Industry Push For More Legislative Support
Generic drugs have saved the U.S. more than $1 trillion over the past decade, a figure that well exceeds predictions from when the Hatch-Waxman Act was enacted in 1984, according to a new study.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives